Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Infection
100%
Antibody Response
100%
Primary Infection
100%
Antibody-dependent Cellular Cytotoxicity
100%
Herpes Simplex Virus Infection
100%
Human Antibody
100%
Novel Animal Model
100%
Herpes Simplex Virus
50%
Knock-in Mouse Model
33%
Herpes Simplex Virus 2 (HSV-2)
33%
Virus Binding
33%
Herpes Simplex Virus Type 1 (HSV-1)
33%
Immune Serum
33%
Neutralizing Response
33%
Mouse Model
16%
Nave
16%
Clinical Trials
16%
Western Blotting
16%
Clinical Response
16%
Vaccine Development
16%
Therapeutic Vaccine
16%
Humoral Immunity
16%
Natural Infection
16%
Passive Transfer
16%
Viral Exposure
16%
Repeated Exposure
16%
Neutralizing Titer
16%
Virus Vaccine
16%
Immune Protection
16%
Mediating Response
16%
Viral Targets
16%
Recurrent Herpes
16%
Recurrent Infections
16%
Immunology and Microbiology
Mouse Model
100%
Antibody Response
100%
Antibody-Dependent Cell-Mediated Cytotoxicity
100%
Herpes Simplex Virus
100%
Infection
100%
Virus Infection
100%
Infectious Disease
50%
Antiserum
33%
Knockout Mouse
33%
Herpes Simplex Virus 2
33%
Human Alphaherpesvirus 1
33%
Virus Attachment
33%
Wild Type
16%
Western Blot
16%
Humoral Immunity
16%
Titer
16%
Herpes Simplex Vaccine
16%